| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |